The basis for treatment in multiple sclerosis

Acta Neurologica Scandinavica

Volumn 113, Issue SUPPL. 183, 2006, Pages 41-47

  Compston, A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Axonal injury; Clinical course; Inflammation; Multiple sclerosis; Remyelination; Treatment

Indexed keywords

ALEMTUZUMAB; NEUROTROPHIN; ANTIINFLAMMATORY AGENT; AUTACOID; IMMUNOLOGICAL ADJUVANT; NERVE GROWTH FACTOR;

AXONAL INJURY; CELL DIFFERENTIATION; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE COURSE; HUMAN; INFLAMMATION; MORBIDITY; MULTIPLE SCLEROSIS; NEUROPROTECTION; RELAPSE; REMYELINIZATION; CONVALESCENCE; MYELIN SHEATH; NERVE FIBER; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ADJUVANTS, IMMUNOLOGIC; ANTI-INFLAMMATORY AGENTS; AXONS; HUMANS; INFLAMMATION MEDIATORS; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE GROWTH FACTORS; RECOVERY OF FUNCTION;

EID: 33645509673     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00614.x     Document Type: Conference Paper

References (40)

1. T rapp BD P eterson J R ansohoff RM R udick R M ork S B o L. Axonal transection in the lesions of multiple sclerosis. New Eng J Med 1998 338 278 85.
2. D avie CA B arker GJ W ebb S et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 1995 118 1583 92.
3. F ilippi M B ozzali M R ovaris M et al. Evidence for widespread axonal damage at the earliest stage of multiple sclerosis. Brain 2003 126 433 37.
4. P rineas JW B arnett MH. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 2004 55 458 68.
5. K utzelnigg A L ucchinetti CF S tadelmann C et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005 128 2705 12.
6. K remenchutzky M R ice GP B askerville J W ingerchuk DM E bers GC. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. Brain 2006 Epub ahead of print.
7. C onfavreux C V ukusic S. Age at disability milestones in multiple sclerosis. Brain 2006 Epub ahead of print.
8. C oles AJ W ing M M olyneux P et al. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neutrol 1999 46 296 304.
9. R ice GP F ilippi M C omi G. Cladribine and progressive MS: clinical and MRI outcomes of a multicenter controlled trial. Cladribine MRI Study Group. Neurology 2000 54 1145 55.
10. C oles AJ L e P age E C ox AL et al. The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy in relapsing-remitting and secondary progressive disease. J Neurol 2006 253 93 108.
11. C onfavreux C V ukusic S M oreau T A deleine P. Relapses and progression of disability in multiple sclerosis. New Eng J Med 2000 343 1430 8.
12. C onfavreux C V ukusic S. Natural history of multiple sclerosis: a unifying concept. Brain 2006 Epub ahead of print.
13. M oreau T C oles A W ing M et al. Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain 1996 119 225 37.
14. R edford EJ K apoor R S mith KJ. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 1997 120 2149 57.
15. S mith KJ K apoor R H all SM D avies M. Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 2001 49 470 6.
16. N icholas RS C ompston A B rown DR. Inhibition of tumour necrosis factor-alpha (TNFalpha)-induced NF-kappaB p52 converts the metabolic effects of microglial-derived TNF alpha on mouse cerebellar neurones to neurotoxicity. J Neurochem 2001 76 1431 8.
17. G olde S C handran S B rown GC C ompston A. Different pathways for iNOS-mediated toxicity in vitro dependent on neuronal maturation and NMDA receptor expression. J Neurochem 2002 82 269 82.
18. W ilkins A C handran S C ompston A. A role for oligodendrocyte-derived IGF-1 in trophic support of cortical neurons. Glia 2001 36 48 57.
19. W ilkins A M ajed H L ayfield R et al. Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. J Neurosci 2003 23 4967 74.
20. Y oul BD T urano G M iller DH et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain 1991 114 2437 50.
21. K aplan MR C ho MH U llian EM I som LL L evinson SR B arres BA. Differential control of clustering of the sodium channels Na(v)1.2 and Na(v)1.6 at developing CNS nodes of Ranvier. Neuron 2001 30 105 19.
22. B oiko T R asband MN L evinson SR et al. Compact myelin dictates the differential targeting of two sodium channel isoforms in the same axon. Neuron 2001 30 91 104.
23. E ngland JD G amboni F L evinson SR F inger TE. Changed distribution of sodium channels along demyelinated axons. Proc Natl Acad Sci USA 1990 87 6777 80.
24. W erring DJ B ullmore ET T oosy AT et al. Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study. J Neurol Neurosurg Psych 2000 68 441 9.
25. K erschensteiner M G allmeier E B ehrens L et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation J Exp Med 1999 189 865 70.
26. W olswijk G. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 2002 125 338 49.
27. N icholas RJ S tevens S W ing MG et al. Microglia-derived IGF-2 and CNTF prevent TNFα induced death of mature oligodendrocytes in vitro. J Neuroimmunol 2002 124 36 44.
28. M ajed H C handran S S pillantini M-G q6 et al. Differential regulation of Plexin-A1 and Neuropilin-1 in microglia: a novel mechanism for semaphorin mediated neuron-microglia interactions. J Neurosci (in press).
29. W ilkins A C ompston A. Trophic factors attenuate nitric oxide mediated neuronal and axonal injury in vitro: roles and interactions of mitogen-activated protein kinase signalling. J Neurochem 2005 92 1487 96.
30. C annella B H oban CJ G ao YL et al. The neuregulin, glial growth factor 2, diminishes autoimune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis. Proc Natl Acad Sci USA 1998 95 10100 5.
31. B utzkueven H Z hang JG S oilu -H anninen M et al. LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat Med 2002 8 613 19.
32. M ason JL X uan S D ragatsis I et al. Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination. J Neurosci 2003 23 7710 18.
33. B arnett SC A lexander CL I washita Y et al. Identification of a human olfactory ensheathing cell that can effect transplant-mediated remyelination of demyelinated CNS axons. Brain 2000 123 1581 8.
34. K ohama I L ankford KL P reiningerova J et al. Transplantation of cryopreserved adult human Schwann cells enhances axonal conduction in demyelinated spinal cord. J Neurosci 2001 21 944 50.
35. J ohn GR S hankar SL S hafit -Z agardo B et al. Multiple Sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 2002 8 1115 21.
36. J urynczyk M J urewicz A B ielecki B R aine CS S elmaj K. Inhibition of Notch signaling enhances tissue repair in an animal model of multiple sclerosis. J Neuroimmunol 2006 170 3 11.
37. S tidworthy MF G enoud S L i WW et al. Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. Brain 2004 127 1928 41.
38. J oannides A G aughwin P S chwiening C et al. Efficient generation of neural precursors from adult human skin: astrocytes promote neurogenesis from skin-derived stem cells. Lancet 2004 364 172 8.
39. P luchino S Q uattrini A B rambilla E et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003 422 688 94.
40. P luchino S Z anotti L R ossi B et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 2005 436 266 71.